Similarly, Hammadah (2017) found that reduced baseline PON1 activity and decreased levels over time were associated with adverse outcomes in heart failure patients, supporting our observation of lower PON1 levels in those with more severe heart failure [26]. Here, PON1 is linked to heart failure.